Certain factors may increase susceptibility to burping and related gastrointestinal symptoms, including: Rapid dose escalation (not following the recommended titration schedule) Concurrent use of other medications affecting gut motility (such as opioids or anticholinergics) Pre-existing gastrointestinal conditions such as gastroparesis or gastroesophageal reflux disease (GERD) Dietary habits that promote gas production Gastrointestinal adverse effects, including burping, are generally more common and pronounced at higher doses, which explains the higher rates observed with Wegovy compared to Ozempic
Taking this weight loss injection every 7 days means no rollercoaster cravings between doses
Months 12+: Long-Term Results Average weight loss: 14-15% by month 16-17 (28-30 pounds for a 200-pound person) In the STEP-1 trial, participants reached their maximum weight loss around week 60-68 (months 14-16)
This documentation serves two purposes
Portha, B., Tourrel-Cuzin, C
Who Is a Good Candidate for GLP-1 Weight Loss Injections